Difference between revisions of "Srivastava A, et al. J. Biomed. Nanotechnol. (2016) cited as Ref 545 in DOI: 10.1038/s41392-020-0110-5 (Q9808)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1166/jbn.2016.2205, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: PubMed ID (P140): 27319211, #quickstatements; #temporary_batch_1590001671040) |
||
| Property / PubMed ID | |||
| + | |||
| Property / PubMed ID: 27319211 / rank | |||
| + | Normal rank | ||
Revision as of 19:19, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Srivastava A, et al. J. Biomed. Nanotechnol. (2016) cited as Ref 545 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Srivastava A
0 references
